Takeda in on ground floor of new US academic alliance
This article was originally published in Scrip
Although it is not providing any direct funding to the initiative at this stage, Takeda is to contribute researchers and expertise to a new early stage drug discovery initiative being set up by three prominent academic institutions in the US.
You may also be interested in...
Novel antifungal T-2307, discovered by FUJIFILM Toyama, works by selectively disrupting mitochondrial function. Excelra and Maruho team up to repurpose existing drugs.
Diversified Japanese giant to launch tender for Danish transplant drug specialist as it looks to build US operations for health care business. Lundbeck and Novo Nordisk among investors that will see an exit.